Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Journal of Mammary Gland Biology and Neoplasia

Issue 3-4/2012

Special Issue: Novel Molecular Targets in Breast Cancer

Content (7 Articles)

Preface

Editorial

Marc Lippman

Epigenetics as a Therapeutic Target in Breast Cancer

Roisin Connolly, Vered Stearns

Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy

Justin Cidado, Ben Ho Park

Targeting Inhibitors of Apoptosis Proteins (IAPs) For New Breast Cancer Therapeutics

Shaomeng Wang, Longchuan Bai, Jianfeng Lu, Liu Liu, Chao-Yie Yang, Haiying Sun

Strategies for Improving the Clinical Benefit of Antiangiogenic Drug Based Therapies for Breast Cancer

Robert S. Kerbel

Translating Mathematical Modeling of Tumor Growth Patterns into Novel Therapeutic Approaches for Breast Cancer

Elizabeth Comen, Patrick G. Morris, Larry Norton

Targeting Insulin and Insulin-Like Growth Factor Signaling in Breast Cancer

Yuzhe Yang, Douglas Yee

Jun 12
Issue: 2/2012
Methods in Mammary Gland Biology and Breast Cancer
Mar 13
Issue: 1/2013
Special Issue: Environmental Risk Factors

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits